The latest closing stock price for Sonnet BioTherapeutics Holdings as of November 20, 2024 is 2.92.
An investor who bought $1,000 worth of Sonnet BioTherapeutics Holdings stock at the IPO in 2006 would have $-1,000 today, roughly -1 times their original investment - a -56.11% compound annual growth rate over 18 years.
The all-time high Sonnet BioTherapeutics Holdings stock closing price was 8007999.01 on October 31, 2006.
The Sonnet BioTherapeutics Holdings 52-week high stock price is 18.72, which is 541.1% above the current share price.
The Sonnet BioTherapeutics Holdings 52-week low stock price is 2.50, which is 14.4% below the current share price.
The average Sonnet BioTherapeutics Holdings stock price for the last 52 weeks is 10.27.
An investor who bought $1,000 worth of Sonnet BioTherapeutics Holdings stock at the IPO in 2006 would have $-1,000 today, roughly -1 times their original investment - a -56.11% compound annual growth rate over 18 years.
The all-time high Sonnet BioTherapeutics Holdings stock closing price was 8007999.01 on October 31, 2006.
The Sonnet BioTherapeutics Holdings 52-week high stock price is 18.72, which is 541.1% above the current share price.
The Sonnet BioTherapeutics Holdings 52-week low stock price is 2.50, which is 14.4% below the current share price.
The average Sonnet BioTherapeutics Holdings stock price for the last 52 weeks is 10.27.